biz.yahoo.com — Tuesday November 4, 2:28 pm ET Discovery Laboratories says it has not received FDA response to updated Surfaxin data WARRINGTON, Pa. (AP) -- Discovery Laboratories Inc. said Tuesday it is still waiting for word from the Food and Drug Administration about review guidelines and timelines for its drug candidate Surfaxin.